Safety and Pharmacokinetics of HR19042 Capsule After Single Administration in Healthy Chinese Subjects
Latest Information Update: 27 Sep 2021
At a glance
- Drugs HR 19042 (Primary)
- Indications IgA nephropathy
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 18 Sep 2021 Status changed from not yet recruiting to completed.
- 19 May 2021 New trial record